BioSpace News Archive

The University of Wisconsin-Madison School of Veterinary Medicine team is advancing cancer care as the first to treat an animal using the Radixact® System with Synchrony®.

Centene Corporation announced that it has commenced an underwritten public offering to sell $1,800,000,000 of senior notes due 2028, subject to market and other conditions.

BetterLife Pharma Inc. is pleased to announce that a joint application to the Mitacs Accelerate program, in collaboration with Dr. Argel Aguilar-Valles at Carleton University Department of Neuroscience, was successfully funded for research into the anti-depressant effects of TD-0148A in preclinical models of chronic depression.

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper on June 10, 2021, entitled “Effects of Transcutaneous Vagal Nerve Stimulation (tVNS/nVNS) on Cognitive Performance under Sleep Deprivation Stress,” in the journal Communications Biology, a Nature publication.

Selecta Biosciences, Inc. today announced the appointment of Nishan de Silva, M.D. to its Board of Directors.

Brickell Biotech, Inc. today announced that its development partner, Kaken Pharmaceutical Co., Ltd. (“Kaken”), recently initiated a Phase 1 clinical study to assess the pharmacokinetics (PK) of sofpironium bromide gel in patients with primary palmoplantar hyperhidrosis (PPH) in Japan.

Aquestive Therapeutics, Inc. announced today the resubmission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Libervant™ (diazepam) Buccal Film for the management of seizure clusters in response to the September 25, 2020 Complete Response Letter (CRL) from the FDA.

Zenith Capital Corp. announces the publication of an important study which has uncovered the role of ZEN-3694.

Longeveron Inc. announced today that an abstract summarizing the results of its Phase 1 trial of Lomecel-B infusion for patients with mild Alzheimer’s disease has been accepted for a Developing Topics poster presentation at the 2021 Annual Alzheimer’s Association International Conference.

Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, announced Dr. Per Djupesland received the European Inventor Award 2021 in the Industry category from the European Patent Office for his invention of the technology that serves as a basis for the Optinose Exhalation Delivery System.